Abbott’s HIV drug Kaletra, faces pre grant opposition in India, Europe – Pharmabiz, 27 August 2007
A US based NGO has filed a pre grant opposition against the patent application filed by Abbott Laboratories Ltd for its ‘heat stable’ form of HIV drug combination lopinavir/ritonavir (kaletra) in the Mumbai Patent Office.